After developing treatments for rare tumors, SpringWorks Therapeutics is taking a buyout offer from Germany-based Merck KGaA.

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...

Merck KGaA has reached an agreement with SpringWorks ... to long-term growth for Merck's healthcare business," said the German group in a statement this morning. SpringWorks will add two FDA ...

As per media reports in February, Merck Germany reacted to press reports and confirmed advanced Online retailer Temu — owned by PDD Holdings (PDD) — aims to raise prices amid tariffs ...

Sebastien Bals, CPO at Merck KGaA Darmstadt Germany, discusses his path of intrigue to one of Germany’s oldest privately held ...

US Treasury secretary Scott Bessent has warned that America’s government debt is on an “unsustainable” path. Donald Trump’s ...

Germany’s Merck KGaA is paying $45 million upfront for rights to a potentially first-in-class drug for colorectal cancer (CRC) being developed by New York biotech Inspirna. The agreement gives ...

Germany’s Federal Office for the Protection of the Constitution has designated AfD as a right-wing extremist organisation, citing xenophobic stances as the reason. Germany’s Federal Office for ...

A remarkable exchange played out on X on Friday as US Secretary of State Marco Rubio accused the government of key ally Germany of “tyranny in disguise” for designating the far-right ...